| Andrea Hamilton, LMSW | |
|
60 N Broadway St, Blackfoot, ID 83221-2706 | |
| (208) 782-3434 | |
| Not Available |
| Full Name | Andrea Hamilton |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 60 N Broadway St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619643962 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | LMSW-41103 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Hamilton, LMSW 60 N Broadway St, Blackfoot, ID 83221-2706 Ph: (208) 782-3434 | Andrea Hamilton, LMSW 60 N Broadway St, Blackfoot, ID 83221-2706 Ph: (208) 782-3434 |
News Archive
Identifying the cell of origin is crucial to understanding how a tumor develops and metastasizes and for developing targeted therapies.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.
Today, Lung Cancer Alliance (LCA) announced that the Department of Veterans Affairs (VA) has agreed to move forward on CT screening for veterans at high risk for lung cancer. This was communicated to Laurie Fenton Ambrose, LCA President & CEO in written correspondence by VA Under Secretary for Health Dr. Robert A. Petzel.
› Verified 6 days ago
Shayna Kearn Norton, LMFT, CADC Counselor Medicare: Medicare Enrolled Practice Location: 288 N Shilling Ave, Blackfoot, ID 83221 Phone: 208-785-1047 | |
Ms. Suzanne Godfrey, LCPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 98 Poplar St, Third Floor, Blackfoot, ID 83221 Phone: 208-785-3800 Fax: 208-785-3876 | |
Kimberley Sweet, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 East Alice Street, Blackfoot, ID 83221 Phone: 208-785-5874 | |
David Scott Hurst, LPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1309 Camas St, Blackfoot, ID 83221 Phone: 208-782-0678 | |
Dallen Ray Bell, LMSW Counselor Medicare: Medicare Enrolled Practice Location: 1309 Camas St, Blackfoot, ID 83221 Phone: 208-782-0675 Fax: 208-782-0678 | |
Mrs. Kathleen S Tomazin, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 90 W Judicial St, Blackfoot, ID 83221 Phone: 208-782-2060 Fax: 208-782-0209 | |
Ruby Lee Walker, LPCP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1441 Parkway Dr, Blackfoot, ID 83221 Phone: 208-785-2600 |